In a report released today, Graig Suvannavejh from Mizuho Securities maintained a Hold rating on Apellis Pharmaceuticals (APLS – Research ...

Salveen Richter, Goldman Sachs lead US biotech analyst for global investment research, joins Market Domination with Josh ...

Thank you for standing by, and welcome to the Apellis Pharmaceuticals fourth quarter and full year 2024 earnings conference call. (Operator Instructions) After the speaker's presentation, there will ...

Goldman Sachs analyst Salveen Richter downgraded Intellia Therapeutics (NTLA) to Sell from Neutral with a price target of $9, down from $12, ...

Alan Ritchson told Business Insider he took a punch from the 7-foot bodybuilder Olivier Richters while filming a fight scene for "Reacher" season three. The third season sees Jack Reacher ...

Salveen Richter; Analyst; Goldman Sachs Group, Inc. Good day, and thank you for standing by. Welcome to the Moderna fourth quarter 2024 conference call. (Operator Instructions) Please be advised, ...

Goldman Sachs US Biotechnology Analyst Salveen Richter explains on "Bloomberg Markets." Moderna Inc. recorded another quarterly loss as vaccine sales wane and the company had an unexpected charge for ...

Goldman Sachs US Biotechnology Analyst Salveen Richter explains on "Bloomberg Markets." UK could face Trump VAT tariff hit; pound hits 2025 high – business live 7 reasons why you feel tired all ...

Salveen Richter, Goldman Sachs: Inquired about BLU-808’s safety profile and potential dosing strategies. CMO Becker Hewes noted the drug’s wide therapeutic index and plans to test various ...

Goldman Sachs analyst Salveen Richter notes that Biogen’s management expects to remain disciplined with regard to capital allocation, pointing to an interest in early-to-mid-stage deals in ...

On the HIV business, Goldman Sachs analyst Salveen Richter says commentary was largely consistent with the recent investor event. The analyst sees challenges in oncology due to competition ...